185 related articles for article (PubMed ID: 11857021)
21. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
[TBL] [Abstract][Full Text] [Related]
22. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.
Wong IH; Yeo W; Leung T; Lau WY; Johnson PJ
Cancer Lett; 2001 Jun; 167(2):183-91. PubMed ID: 11369140
[TBL] [Abstract][Full Text] [Related]
23. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
24. [Expression of MAGE-B genes in hepatocellular carcinoma].
Mou DC; Leng XS; Peng JR; Zhao L; Wang WX; Wang Y; Li T; Zhang LG; Huang L; Zhu JY
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):40-2. PubMed ID: 15059354
[TBL] [Abstract][Full Text] [Related]
25. Detection of circulating tumor cells by reverse transcription‑quantitative polymerase chain reaction and magnetic activated cell sorting in the peripheral blood of patients with hepatocellular carcinoma.
Guo L; Xu D; Lu Y; Peng J; Jiang L
Mol Med Rep; 2017 Nov; 16(5):5894-5900. PubMed ID: 28849093
[TBL] [Abstract][Full Text] [Related]
26. Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma.
Cui Z; Yu X; Guo L; Wei Y; Zheng S; Li W; Chen P; Zhu J; Peng J
Dis Markers; 2013; 35(6):915-23. PubMed ID: 24427779
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
Lemoine A; Le Bricon T; Salvucci M; Azoulay D; Pham P; Raccuia J; Bismuth H; Debuire B
Ann Surg; 1997 Jul; 226(1):43-50. PubMed ID: 9242336
[TBL] [Abstract][Full Text] [Related]
28. Expression of AFPmRNA in blood of patients with recurrent hepatocellular carcinoma.
Liu Y; Zhang BH; Qian GX; Chen H; Wu MC
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):274-7. PubMed ID: 14599983
[TBL] [Abstract][Full Text] [Related]
29. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
[TBL] [Abstract][Full Text] [Related]
30. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood.
Komeda T; Fukuda Y; Sando T; Kita R; Furukawa M; Nishida N; Amenomori M; Nakao K
Cancer; 1995 May; 75(9):2214-9. PubMed ID: 7536120
[TBL] [Abstract][Full Text] [Related]
31. Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
Sheen IS; Jeng KS; Shih SC; Wang PC; Chang WH; Wang HY; Shyung LR; Lin SC; Kao CR; Tsai YC; Wu TY
World J Gastroenterol; 2004 Jan; 10(1):31-6. PubMed ID: 14695764
[TBL] [Abstract][Full Text] [Related]
32. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation.
Waguri N; Suda T; Nomoto M; Kawai H; Mita Y; Kuroiwa T; Igarashi M; Kobayashi M; Fukuhara Y; Aoyagi Y
Clin Cancer Res; 2003 Aug; 9(8):3004-11. PubMed ID: 12912949
[TBL] [Abstract][Full Text] [Related]
33. [Molecular markers of micrometastasis in the blood of hepatocellular carcinoma patients].
Stokowska A; Stalke P; Bielawski KP
Postepy Hig Med Dosw (Online); 2007 May; 61():310-9. PubMed ID: 17554234
[TBL] [Abstract][Full Text] [Related]
34. [Expression of MAGE-1 gene in hepatocellular carcinoma].
Cai S; Chen H; Wang Y
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):668-72. PubMed ID: 11715455
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
Iavarone M; Lampertico P; Ronchi G; Del Ninno E; Zanella A; Colombo M
J Viral Hepat; 2003 Nov; 10(6):423-6. PubMed ID: 14633174
[TBL] [Abstract][Full Text] [Related]
36. Circulating Hepatocellular Cells are a Bad Prognostic Factor for HCC Patients.
Liu Y; Wang YR; Wang L; Xun LJ; Ding GH; Yao L
Hepatogastroenterology; 2015 Jun; 62(140):802-6. PubMed ID: 26902005
[TBL] [Abstract][Full Text] [Related]
37. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
38. Serum tumor markers for detection of hepatocellular carcinoma.
Zhou L; Liu J; Luo F
World J Gastroenterol; 2006 Feb; 12(8):1175-81. PubMed ID: 16534867
[TBL] [Abstract][Full Text] [Related]
39. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Morimoto O; Nagano H; Miyamoto A; Fujiwara Y; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Surg Today; 2005; 35(12):1033-41. PubMed ID: 16341483
[TBL] [Abstract][Full Text] [Related]
40. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
